301277.SZ
Newland Pharmaceutical Co., Ltd.
SZSE · C 制造业 · CN
CNY 9.34
+1.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.20x
- PEG TTM
- —
- Price / book
- 2.39x
- Price / sales
- 5.26x
- Price / cash flow
- 56.96x
Enterprise value
- Enterprise value
- CNY 3.3B
- EV / sales
- 5.08x
- EV / EBITDA
- 17.63x
- EV / EBIT
- 30.02x
- Market cap
- CNY 3.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026